Status:
COMPLETED
Non-invasive Measures of Distal Lung Disease in Asthmatics
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
This is a Phase 4, single center study conducted in mild-to moderate asthmatics.
Detailed Description
The study consists of 3 phases. There are 7 study visits.
Eligibility Criteria
Inclusion
- 18-65 years old
- Currently using SABA prn or a low-to-moderate persistent asthma
Exclusion
- Tobacco use within 1 year or \>= 5 pack years
Key Trial Info
Start Date :
September 30 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2007
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00250341
Start Date
September 30 2005
End Date
September 30 2007
Last Update
December 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095